Clinical Trials in Minneapolis

Showing 2321-2340 of 6,957 trials

Health Promotion of People With Disabilities

NCT00164489

This research is meant to evaluate the effectiveness of two different prevention programs for post-acute management of rheumatoid and osteo-arthritis

Rheumatoid and Osteoarthritis

Centers for Disease Control and Prevention400 participantsStarted Oct 2003

Minneapolis, Minnesota, United States

COMPLETED< 1 mile

Using Smartphone Sensor Technology to Characterize Ambulatory Patterns of Participants With Peripheral Artery Disease

NCT04124315

The investigators plan to use smartphone and wearable sensor technology to characterize the activity patterns of participants with peripheral artery disease (PAD) (n=24) participating in a 12-week supervised exercise training (SET) program, and incorporate the resulting data into a web-based dashboard for participants and study staff.

Peripheral Artery Disease

University of Minnesota19 participantsStarted Nov 2021

Minneapolis, Minnesota, United States

TERMINATEDPhase 3< 1 mile

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

NCT02548351

The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver-related clinical outcomes in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.

Non Alcoholic Steatohepatitis (NASH)

Intercept Pharmaceuticals2,477 participantsStarted Sep 2015

Birmingham, Alabama, United States • Dothan, Alabama, United States • Chandler, Arizona, United States +343 more locations

Health Promotion of People With Disabilities

Using Smartphone Sensor Technology to Characterize Ambulatory Patterns of Participants With Peripheral Artery Disease

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Find Trials by Condition in Minneapolis

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

WHOOP ECG Software Performance Assessment Study

Open-Label Extension Study of Trofinetide for Rett Syndrome

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Observational Study of Obstructive Lung Disease (NOVELTY)

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

BALANCE+ Vanguard Phase

Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)